[Lupus anticoagulant-hypoprothrombinemia syndrome associated with follicular lymphoma].

Koyama, Daisuke; Hanajiri, Ryo; Kanematsu, Takeshi; Ito, Rie; Yamamoto, Satomi; Imoto, Naoto; Suzuki, Nobuaki; Kurahashi, Shingo; Sugiura, Isamu

Koyama, Daisuke; Hanajiri, Ryo; Kanematsu, Takeshi; Ito, Rie; Yamamoto, Satomi; Imoto, Naoto; Suzuki, Nobuaki; Kurahashi, Shingo; Sugiura, Isamu.

Afiliação

Koyama D; Division of Hematology and Oncology, Toyohashi Municipal Hospital.
Hanajiri R; Division of Hematology and Oncology, Toyohashi Municipal Hospital.
Kanematsu T; Department of Clinical Laboratory, Nagoya University Hospital.
Ito R; Division of Hematology and Oncology, Toyohashi Municipal Hospital.
Yamamoto S; Division of Hematology and Oncology, Toyohashi Municipal Hospital.
Imoto N; Division of Hematology and Oncology, Toyohashi Municipal Hospital.
Suzuki N; Department of Transfusion Medicine, Nagoya University Hospital.
Kurahashi S; Division of Hematology and Oncology, Toyohashi Municipal Hospital.
Sugiura I; Division of Hematology and Oncology, Toyohashi Municipal Hospital.

Rinsho Ketsueki ; 61(7): 745-749, 2020.

Article em Ja | MEDLINE | ID: mdl-32759560

Assuntos

Síndrome Antifosfolipídica; Hipoprotrombinemias; Linfoma Folicular; Feminino; Humanos; Inibidor de Coagulação do Lúpus; Pessoa de Meia-Idade; Recidiva Local de Neoplasia; Tempo de Tromboplastina Parcial; Tempo de Protrombina

Palavras-chave

Acquired coagulopathy; Follicular lymphoma; Lupus anticoagulant-hypoprothrombinemia syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Síndrome Antifosfolipídica / Hipoprotrombinemias Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: Ja Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google